Patents
Patents for C07D 513 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for in groups , or (15,120)
11/2014
11/18/2014US8889862 2-amino-4-arylthiazole compounds as TRPA1 antagonists
11/18/2014US8889856 Tetrahydropyrrolothiazine compounds
11/18/2014US8889718 Thiazole derivatives
11/18/2014US8889678 Acyl guanidine derivatives modulating the hedgehog protein signaling pathway
11/13/2014US20140336184 Method to enhance cognition
11/13/2014US20140336177 Inhibitors of the renal outer medullary potassium channel
11/13/2014US20140336158 Nk1 antagonists
11/11/2014US8884023 Pyrano [3,2-D][1,3]thiazole as glycosidase inhibitors
11/11/2014US8883954 Photoactive polymers
11/11/2014US8883833 Substituted benzoazole PDE4 inhibitors for treating inflammatory, cardiovascular and CNS disorders
11/11/2014US8883828 2-aminopyridine analogs as glucokinase activators
11/11/2014US8883819 Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension
11/11/2014US8883807 Piperidinone carboxamide indane CGRP receptor antagonists
11/11/2014US8883789 Piperazine derivatives and their use as positive allosteric modulators of mGluR5 receptors
11/11/2014US8883784 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
11/11/2014US8883783 Solid forms comprising N-(5-tert-butyl-isoxazol-3-yl)-N′-{4-[7-(2-morpholin-4-yl-ethoxy)imidazo[2,1-b][1,3]benzothiazol-2-yl]phenyl}urea, compositions thereof, and uses therewith
11/11/2014US8883758 3,5-disubstituted and 3,5,7-trisubstituted-3H-oxazolo and 3H-thiazolo[4,5-d]pyrimidin-2-one compounds and prodrugs thereof
11/06/2014US20140329820 Triazine Derivatives
11/06/2014US20140329800 Tri-heterocyclic derivatives, preparation process and uses thereof
11/06/2014US20140329799 Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
11/06/2014US20140329798 Substituted cyclopropyl compounds useful as gpr119 agonists
10/2014
10/30/2014US20140323474 Hexahydropyrano[3,4-d][1,3]Thiazin-2-Amine Compounds
10/30/2014US20140323450 Combination compositions and methods of treatment
10/28/2014US8871929 Fused-imidazoyl compounds useful as antimicrobial agents
10/28/2014US8871769 Ureas and their use in the treatment of heart failure
10/28/2014US8871760 [1,2,4]triazolo[3,4-C][1,4]oxazines as P2X7 modulators
10/23/2014US20140315945 Substituted Benzene Compounds
10/23/2014US20140315896 Benzopyranobenzothiazinones and their use as fungicides, antibiotics and antitumor agents
10/23/2014US20140315885 Therapeutically Active Thiazolo-Pyrimidine Derivatives
10/21/2014US8865758 Pyrazolo piperidine derivatives as NADPH oxidase inhibitors
10/21/2014US8865753 Compounds as cannabinoid receptor ligands
10/21/2014US8865750 Small molecule inhibitors of RGS proteins
10/21/2014US8865736 Antibacterial agents
10/21/2014US8865727 Method for treating pain syndrome and other disorders
10/21/2014US8865720 Sulfonyl-derivatives as novel inhibitors of histone deacetylase
10/21/2014US8865713 Benzoimidazoles as prolyl hydroxylase inhibitors
10/21/2014US8865706 Heteroaryl-substituted hexahydropyrano[3,4-d][1,3]thiazin-2-amine compounds
10/21/2014US8865701 Spiropyrrolidine beta-secretase inhibitors for the treatment of alzheimer'S disease
10/16/2014US20140309222 Therapeutically Active Fused Pyrimidine Derivatives
10/16/2014US20140309218 3,7-disubstituted octahydro-2h-pyrido[4,3-e][1,3]oxazin-2-one antibiotics
10/14/2014US8859814 Alpha-substituted N-sulfonyl gylcine amides antagonists of CCR10, compositions containing the same and methods for using them
10/14/2014US8859717 Nitrogen-containing fused ring compound, nitrogen-containing fused ring polymer, organic thin film, and organic thin film element
10/14/2014US8859583 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
10/14/2014US8859582 Bicyclic heterocyclic compounds as protein tyrosine kinase inhibitors
10/14/2014US8859563 Bicyclic pyrimidinones and uses thereof
10/09/2014WO2014164708A1 Histone dementhylase inhibitors
10/09/2014WO2014164428A1 Inhibitors of human immunodeficiency virus replication
10/09/2014US20140303372 Sulfonylpyrazole and sulfonylpyrazoline carboxamidine derivatives as 5-ht6 antagonists
10/09/2014US20140303150 Ingenol-3-acylates iii and ingenol-3-carbamates
10/09/2014US20140303144 Compounds and methods of treating hypertension
10/07/2014USRE45183 Heteroaryl-ureas and their use as glucokinase activators
10/07/2014US8853249 Method for producing intermediates for the production of macrocycles that are inhibitors of the proteasomic degradation of p27, such as argyrin and derivatives thereof
10/07/2014US8853238 Fused heterocyclic compound and use thereof for pest control
10/07/2014US8853237 Naphthyridinone analogs as mGluR5 positive allosteric modulators
10/07/2014US8853234 Quinolone analogs and methods related thereto
10/07/2014US8853215 Derivatives of N-acyl-N′-phenylpiperazine useful (inter alia) for the prophylaxis or treatment of diabetes
10/02/2014WO2014160430A1 Small molecule lrrk2 and erk5 inhibitors
10/02/2014WO2014157653A1 Processes for preparing optically active diamine derivatives
10/02/2014WO2014157494A1 Material for organic electroluminescent elements, organic electroluminescent element, display device and lighting device
10/02/2014WO2014156878A1 Organic thin-film transistor
10/02/2014US20140296226 Amino-Oxazine and Amino-Dihydrothiazine Compounds as Beta-Secretase Modulators and Methods of Use
10/02/2014US20140296205 Selective glycosidase inhibitors and uses thereof
10/02/2014US20140296169 Isothiazolopyridine-2-carboxamides and their use as pharmaceuticals
10/01/2014EP2784078A1 Benzoxepin pi3k inhibitor compounds and methods of use
09/2014
09/30/2014US8846951 Modulators of 5-HT receptors and methods of use thereof
09/30/2014US8846947 Benzimidazoles and related analogs as sirtuin modulators
09/30/2014US8846927 Inhibitors of protein tyrosine kinase activity
09/30/2014US8846906 5HT2C receptor modulators
09/30/2014US8846762 Benzopyran and benzoxepin PI3K inhibitor compounds and methods of use
09/30/2014US8846712 6-(4-hydroxy-phenyl)-3-styryl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
09/30/2014US8846694 Pyrrolidone derivatives for use as MetAP-2 inhibitors
09/30/2014US8846665 6,7-dihydro-[1,3,4]thiadiazolo-[3,2-a][1,3]diazepin derivative and pharmaceutical composition containing the same as neuromuscular blocker or skeletal muscle relaxant, and method for the preparation
09/30/2014US8846664 Pyrazinopyrazines and derivatives as kinase inhibitors
09/25/2014WO2014148614A1 Organic thin film transistor
09/25/2014US20140288302 Acetic acid amide derivative having inhibitory activity on endothelial lipase
09/25/2014US20140288048 Heterocyclic compounds and uses thereof
09/23/2014US8841462 Bicyclic heterocycles as MEK kinase inhibitors
09/23/2014US8841410 Nitrogen-containing condensed ring compound, nitrogen-containing condensed ring polymer, organic thin film, and organic thin film element
09/23/2014US8841293 Tetrahydropyrrolothiazine compounds
09/18/2014WO2014143672A1 Macrocyclic compounds as irak4 inhibitors for the treatment of inflammatory diseases
09/18/2014WO2014143579A1 Tetrahydropyrrolothiazine compounds
09/18/2014WO2014140313A1 Macrocyclic salt-inducible kinase inhibitors
09/18/2014WO2014140299A1 Macrocyclic rip2 kinase inhibitors
09/18/2014US20140275065 Substituted 7-azabicyles and their use as orexin receptor modulators
09/18/2014US20140275064 Dyrk1 inhibitors and uses thereof
09/18/2014US20140275044 Tetrahydropyrrolothiazine compounds
09/18/2014US20140275024 Dna-pk inhibitors
09/18/2014US20140275022 Selective glycosidase inhibitors and uses thereof
09/17/2014EP2776445A1 Therapeutically active thiazolo-pyrimidine derivatives
09/16/2014US8835626 Materials for organic electroluminescent devices
09/16/2014US8835442 3-substituted 7-imino-2-thioxo-3, 7-dihydro-2H-thiazolo [4,5-di pyrimidin-6-yl—and process for preparation thereof
09/16/2014US8835437 Piperidine/piperazine derivatives
09/16/2014US8835393 Inhibitors of IAP
09/12/2014WO2014135480A1 Substituted thiazolopyrimidines
09/11/2014US20140256936 Diarylethene compounds and uses thereof
09/11/2014US20140256933 Tetrahydropyrrolothiazine compounds
09/11/2014US20140256733 Mixed lineage kinase inhibitors and method of treatments
09/11/2014US20140256722 Benzoimidazoles as prolyl hydroxylase inhibitors
09/11/2014US20140256717 Macrocyclic compounds as protein kinase inhibitors
09/11/2014US20140255386 Microrna modulators and method for identifying and using the same
1 2 3 4 5 6 7 8 9 10 11 12 13 ... 152